☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Stuart Therapeutics
Stuart Therapeutics Reports First Patient, First Visit in the P-III Study of Vezocolmitide for Treating Dry Eye Disease
January 1, 2024
Stuart Therapeutics Entered into an Exclusive License Agreement with Glaukos Corporation to Develop the First Neuroprotective Ther...
October 19, 2023
Load more...
Back to Home